Pursuant to section 106(1) of the Medicines Act 1981,
I, Dr Don Mackie, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health, acting under delegated authority,
hereby declare the following:
1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) preparations and admixtures containing any proportion of any substance listed in the notice.
(b) salts and esters of any substance listed in the notice.
(c) preparations or extracts of biological materials listed in the notice.
(d) salts or oxides of elements listed in the notice.
Unless specific reference is made otherwise, every reference to a medicine applies:
(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and
(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using
the free acid, base, alcohol or element unless specifically stated otherwise.
Schedule 1
Prescription Medicines
Abiraterone acetate
Axitinib
Cobicistat
Elvitegravir
Febuxostat
Influenza vaccine; except when administered to a person
18 years of age or over by a registered pharmacist
who has successfully completed a vaccinator training course approved by the Ministry of Health and who
is complying with the immunisation standards of the Ministry of Health
Oseltamivir; except when specified elsewhere in this notice
Vilanterol
Schedule 2
Restricted Medicines
Adrenaline; in medicines containing 1% or less except in medicines for injection containing 0.02% or less
Ciclopirox; for external use in medicines containing more than 2%; in preparations for application to the nails containing more than 8%
Oseltamivir; in solid dosage forms for oral use containing
75 milligrams in a pack size of up to 10 dosage units for the treatment or prophylaxis of influenza in adults and children aged 13 years and older who have been exposed to the influenza virus
Schedule 3
Pharmacy-only Medicines
Ciclopirox; for external use in medicines containing 2% or less except when for the treatment of tinea pedis only
or when sold in practice by a podiatrist registered with the Podiatrists Board; in preparations for application
to the nails containing 8% or less
Medicines for General Sale
Please note that the following medicines are now available for general sale.
Adrenaline; in medicines for injection containing 0.02%
or less
Ciclopirox; for external use in medicines containing 2% or less when for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Dated this 30th day of January 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health.